These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 6572032

  • 1. Properdin factor B (Bf) and glyoxalase in Graves' disease.
    Allannic H, Fauchet R, Lorcy Y, Phengsavath H, Gueguen M, Knoi TD, Genetet B, Le Gall JY.
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):57-61. PubMed ID: 6572032
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Factor B (Bf) and glyoxalase genes in insulin-dependent diabetes mellitus.
    Allannic H, Fauchet R, Gueguen M, Pheng Savath H, Dinh Knoi T, Genetet B.
    Diabete Metab; 1985 Feb; 11(1):22-6. PubMed ID: 3856541
    [Abstract] [Full Text] [Related]

  • 4. HLA antigens associated with properdin factor B allotype BfF1.
    Dyer PA, Klouda PT, Harris R.
    Tissue Antigens; 1981 Feb; 17(4):362-7. PubMed ID: 6949335
    [Abstract] [Full Text] [Related]

  • 5. Genetic susceptibility to diabetes mellitus: the distribution of properdin factor B (Bf) and glyoxalase (GLO) phenotypes.
    Kirk RL, Theophilus J, Whitehouse S, Court J, Zimmet P.
    Diabetes; 1979 Oct; 28(10):949-51. PubMed ID: 478186
    [Abstract] [Full Text] [Related]

  • 6. HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM).
    Cambon-de Mouzon A, Ohayon E, Hauptmann G, Sevin A, Abbal M, Sommer E, Vergnes H, Ducos J.
    Tissue Antigens; 1982 May; 19(5):366-79. PubMed ID: 6955994
    [Abstract] [Full Text] [Related]

  • 7. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM, Barnard J, Farid N, Marshall WH, Murphy L, Rideout D, Taylor R, Xidos G, Larsen B.
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [Abstract] [Full Text] [Related]

  • 8. Polymorphism of BF, C2, and GLO in Japanese patients with insulin-dependent diabetes mellitus: confirmation of an increase of BF*FT.
    Tokunaga K, Omoto K, Juji T, Itoh T.
    Hum Genet; 1982 Apr; 62(1):86-8. PubMed ID: 6924917
    [No Abstract] [Full Text] [Related]

  • 9. HLA, complement C2, C4, properdin factor B and glyoxalase types in South Indian diabetics.
    Kirk RL, Ranford PR, Serjeantson SW, Thompson AR, Munirathnam Chetty SM, John L, Mohan V, Ramachandran A, Snehalatha C, Viswanathan M.
    Diabetes Res Clin Pract; 1985 Mar; 1(1):41-7. PubMed ID: 3879724
    [Abstract] [Full Text] [Related]

  • 10. Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population.
    Regueiro JR, Arnaiz-Villena A.
    Tissue Antigens; 1988 Jan; 31(1):14-25. PubMed ID: 3341017
    [Abstract] [Full Text] [Related]

  • 11. [Genetic factors Bf and glyoxalase in Basedow's disease].
    Allannic H, Fauchet R, Lorcy Y, Phengsavath H, Guéguen M, Dinh KT, Le Gall JY, Genétet B.
    Rev Med Interne; 1982 Jun; 3(2):129-32. PubMed ID: 6924395
    [No Abstract] [Full Text] [Related]

  • 12. HLA-A,B,C, and DR antigens, GLO I and Bf marker profiles in 75 Cape coloured patients with systemic lupus erythematosus (SLE).
    Klemp P, du Toit ED, Issacs S, Mody GM, Oudshoorn M.
    Tissue Antigens; 1988 Jul; 32(1):12-6. PubMed ID: 3187991
    [Abstract] [Full Text] [Related]

  • 13. Red cell glyoxalase I polymorphism in Alsace, France: linkage of GLO with Bf.
    North ML, Amann I, Tongio MM, Hauptmann G, Klein J, Mayer S.
    Hum Hered; 1981 Jul; 31(1):39-41. PubMed ID: 6910464
    [No Abstract] [Full Text] [Related]

  • 14. Mapping of the linkage group GLO--Bf--HLA-B,C,A--PGM3. 1. Recombination frequencies.
    Kömpf J, Bissbort S, Göhler F, Schunter F, Wernet P.
    Hum Genet; 1978 Nov 16; 44(3):313-9. PubMed ID: 730169
    [Abstract] [Full Text] [Related]

  • 15. Mapping of the linkage group GLO--Bf--HLA-B,C,A--PGM3. 2. Segregation analysis.
    Schunter F, Wernet P, Kömpf J, Bissbort S, Göhler F.
    Hum Genet; 1978 Nov 16; 44(3):321-31. PubMed ID: 730170
    [Abstract] [Full Text] [Related]

  • 16. Distribution of properdin factor B and glyoxalase I (further genetic markers) in Northern Ireland.
    Hamilton P, Middleton D.
    Ulster Med J; 1988 Apr 16; 57(1):41-4. PubMed ID: 3166548
    [Abstract] [Full Text] [Related]

  • 17. Association of glyoxalase I allotypes with Graves' disease and diabetes mellitus.
    Moens H, Payne R, Carter ND, Farid NR.
    Hum Hered; 1980 Apr 16; 30(1):62-4. PubMed ID: 6892568
    [Abstract] [Full Text] [Related]

  • 18. An unusual "morphologic" variant of BF S.
    Raum D, Surgenor T, Awdeh Z, Marcus D, Blumenthal M, Yunis EJ, Alper CA.
    Am J Hum Genet; 1984 Mar 16; 36(2):346-51. PubMed ID: 6585138
    [Abstract] [Full Text] [Related]

  • 19. Properdin factor B(Bf) allele BfF1 specifies an HLA-B18 diabetogenic haplotype.
    Dornan J, Allan P, Noel EP, Larsen B, Farid NR.
    Diabetes; 1980 Jun 16; 29(6):423-7. PubMed ID: 6929767
    [Abstract] [Full Text] [Related]

  • 20. Properdin factor B polymorphism in four Sardinian villages.
    Borelli I, Olivetti E, Cappello N, Rendine S, Curtoni ES.
    Hum Hered; 1987 Jun 16; 37(4):217-21. PubMed ID: 3653902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.